Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1995-9-22
|
| pubmed:abstractText |
CD7 is a 40-kDa transmembrane glycoprotein member of the lg gene superfamily expressed on most peripheral blood T lymphocytes and NK cells. CD7 is also expressed on myeloid, NK, B, and T cell precursors during adult hematopoiesis. Because Thy-1 is absent in human thymocytes and peripheral blood T cells and shows structural similarities to the human CD7 gene, we have suggested that human CD7 may be a functional homologue in humans of mouse Thy-1. To study the tissue-specific expression of the CD7 gene utilizing its own promoter, we constructed transgenic mice that contained both the coding and flanking regions of the human CD7 gene. We found that human CD7 was expressed in transgenic mice in T, B, NK, and myeloid lineages and was induced with T cell activation. Unlike the expression of CD7 in humans, the CD7 transgene was present on mature B lymphocytes and macrophages. Like mouse Thy-1, transgenic human CD7 was expressed in immature and mature T cells and in Sca-1+ bone marrow mononuclear cells. Unlike mouse Thy-1, the human CD7 transgene was not expressed in mouse brain or fibroblasts. The human CD7 transgene was expressed during fetal development before mouse Thy-1 in fetal liver mononuclear cells. Expression of the human CD7 transgene did not alter mouse thymopiesis or Thy-1 expression. Taken together, these data demonstrated that the CD7 transgene contained sufficient regulatory regions to direct hematopoietic expression and mitogenic induction. The pattern of CD7 transgene expression more closely resembled that of CD7 in humans than that of mouse Thy-1.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0022-1767
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
155
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2407-18
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:7544374-Animals,
pubmed-meshheading:7544374-Antigens, CD,
pubmed-meshheading:7544374-Antigens, CD7,
pubmed-meshheading:7544374-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:7544374-Antigens, Thy-1,
pubmed-meshheading:7544374-Bone Marrow,
pubmed-meshheading:7544374-Bone Marrow Cells,
pubmed-meshheading:7544374-Gene Expression,
pubmed-meshheading:7544374-Gene Expression Regulation, Developmental,
pubmed-meshheading:7544374-Hematopoietic Stem Cells,
pubmed-meshheading:7544374-Humans,
pubmed-meshheading:7544374-Lymphocyte Activation,
pubmed-meshheading:7544374-Lymphocyte Subsets,
pubmed-meshheading:7544374-Mice,
pubmed-meshheading:7544374-Mice, Transgenic,
pubmed-meshheading:7544374-Organ Specificity,
pubmed-meshheading:7544374-Spleen,
pubmed-meshheading:7544374-T-Lymphocytes,
pubmed-meshheading:7544374-Thymus Gland
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Characterization of human CD7 transgenic mice.
|
| pubmed:affiliation |
Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|